National Institutes Of Health Selects Openclinica For National Autism Research Program
The NIH’s National Database for Autism Research program selects OpenClinica to provide research tools to autism researchers.
CAMBRIDGE, MA (PRWEB) June 3, 2006 —
Akaza Research has been selected to implement OpenClinica Enterprise as the clinical assessment component of The National Database for Autism Research (NDAR). NDAR is a collaborative biomedical informatics system being created by the National Institutes of Health to accelerate research in autism.
Clinical assessments are typically paper forms that are completed by hand for each subject. The NDAR OpenClinica system will feature an electronic catalogue of assessments that are most commonly used in autism research, and will enable researchers to develop protocols for clinical trials, and enter clinical assessment data electronically.
As a result it will be easier and faster for researchers to gather, evaluate, and share autism research data from a variety of sources. By giving researchers access to more data than they can collect on their own and making their own data collection efforts more efficient, the time to discovery can be reduced.
NDAR supports informatics across a range of autism research activities, including genomics, imaging, laboratory, clinical, and behavioral data sources. With OpenClinica, it will provide the core technology for a data warehouse, a data-entry system, and a centralized source for common measures and their documentation. It will support large-scale, multi-site projects as well as pilot studies and basic science investigations. For more information, see http://ndar. nih. gov/ (http://ndar. nih. gov/)
About OpenClinica
OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica supports HIPAA and 21 CRF Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. OpenClinica v1.0 was released in October 2005 under the GNU Lesser General Public License (LGPL). See www. OpenClinica. org. OpenClinica 2.0 is scheduled to be released to beta testers this summer.
About Akaza Research
Akaza Research, LLC, is the leading provider of open source clinical informatics software. The company is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based systems accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www. akazaresearch. com.
# # #